menu
    • menu

    Company profile for ChemomAb

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ChemomAb is a clinical-stage biotech company focusing on the development of targeted innovative therapeutics for fibrosis-related diseases with great unmet need. ChemomAb is planning to initiate three Phase II clinical trials in the orphan indications Primary Sclerosing Cholangitis and Systemic Sclerosis, as well as in non-alcoholic steatohepatitis (NASH) patients, supported by the company's lead investors that include OrbiMed...
    ChemomAb is a clinical-stage biotech company focusing on the development of targeted innovative therapeutics for fibrosis-related diseases with great unmet need. ChemomAb is planning to initiate three Phase II clinical trials in the orphan indications Primary Sclerosing Cholangitis and Systemic Sclerosis, as well as in non-alcoholic steatohepatitis (NASH) patients, supported by the company's lead investors that include OrbiMed and Thiel Capital.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChemomAbIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    ChemomAb Ltd. Kiryat Atidim, Building 7, Entrance 2 Tel Aviv
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.chemomab.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ChemomAb Therapeutics Joins Oppenheimer Healthcare Conference
    ChemomAb Therapeutics Joins Oppenheimer Healthcare Conference

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239224/0/en/Chemomab-Therapeutics-to-Participate-in-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    AJG Publishes Chemomab's Nebokitug Phase 2 SPRING PSC Trial
    AJG Publishes Chemomab's Nebokitug Phase 2 SPRING PSC Trial

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197838/0/en/Chemomab-Therapeutics-Announces-Nebokitug-Phase-2-SPRING-Trial-Results-in-Primary-Sclerosing-Cholangitis-Published-in-the-American-Journal-of-Gastroenterology.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Chemomab Joins Oppenheimer's Rare Disease Summit
    Chemomab Joins Oppenheimer's Rare Disease Summit

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193438/0/en/Chemomab-to-Participate-in-Oppenheimer-s-Movers-in-Rare-Disease-Summit.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Chemomab Therapeutics Reports Q3 2025 Results and Corporate
    Chemomab Therapeutics Reports Q3 2025 Results and Corporate

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191873/0/en/Chemomab-Therapeutics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Chemomab Presents Nebokitug Ph 2 Trial Data At AASLD
    Chemomab Presents Nebokitug Ph 2 Trial Data At AASLD

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182478/0/en/Chemomab-Announces-Multiple-Presentations-at-AASLD-The-Liver-Meeting-2025-Featuring-Clinical-Data-from-the-Nebokitug-Phase-2-Trial-in-Primary-Sclerosing-Cholangitis.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Chemomab Therapeutics at H.C. Wainwright 27th Global Conference
    Chemomab Therapeutics at H.C. Wainwright 27th Global Conference

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137088/0/en/Chemomab-Therapeutics-to-Present-at-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search